Tech Company Financing Transactions

Freenome Funding Round

Polaris Partners, RA Capital and Andreessen Horowitz participated in a $160 million Series B funding round for Freenome. This venture round closed on 7/25/2019.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

279 East Grand Ave. 5th Floor
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.freenome.com

Email Address

[email protected]

Overview

Freenome is the dynamic collection of genetic material floating in your blood (cell-free) derived from the trillions of cells in your body. It is your living cell-free genome changing over time and space.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gabriel Otte

        

Chief Financial Officer

William Quirk

        

Chief Medical Officer

Girish Putcha

        

Chief Operating Officer

Riley Ennis

        

Chief Scientific Officer

Jimmy Lin

        

VP - Bus. Development

Michael Nolan

        

VP - Client Services

Charles Roberts

        

Browse more venture capital transactions:

Prev: 7/25/2019: Benchling venture capital transaction
Next: 7/25/2019: Hippo venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary